In the rapidly evolving landscape of clinical trials, technology continues to reshape and optimise various aspects of the research process. One area where digital innovation has made significant strides is in the realm of electronic consent, or e-consent. This approach to obtaining participant consent leverages the power of digital platforms to streamline and enhance the enrollment experience. By eliminating cumbersome paper-based processes, e-consent makes the consent process more efficient, accessible, and user-friendly. Participants can conveniently review and provide consent remotely, overcoming geographical barriers and expanding the reach of clinical trials. Additionally, interactive features and multimedia elements incorporated in e-consent platforms foster better participant comprehension, empowering individuals to make informed decisions about their participation.
In this blog post, we highlight ten companies that excel in providing solutions for e-consent and prescreening needs, enabling clinical trial professionals to conduct their research with greater ease and effectiveness.
- Sano Genetics offers advanced e-consent solutions that empower researchers and participants to navigate the precision medicine clinical trial consent process seamlessly. Their user-friendly platform employs state-of-the-art encryption measures, personalised consent forms, and transparent data management practices, ensuring privacy and compliance.
- Medidata provides e-consent services in a secure and streamlined way, enabling patients to make informed decisions about participating in clinical trials through an intuitive interface while also providing researchers with real-time tracking.
- Florence Healthcare offers comprehensive e-consent services to digitise the consent process, enabling remote collaboration, electronic signatures, and centralised document management through a cloud-based platform.
- Veeva has built an e-consent solution that leverages industry-leading technology to ensure regulatory compliance, simplify consent, and enable integration with other clinical systems.
- DrugDev (a part of IQVIA) provides an e-consent solution that takes learning theory into account and enables remote consenting, real-time document tracking, and consent version control.
- Signant Health has built Signant SmartSignals eConsent, which provides researchers with e-consent services that employ varying degrees of technology based on need and ensures audit readiness and re-consenting ability.
- Science 37 provides innovative e-consent solutions that enable decentralised clinical trials; their offering include remote consenting via telehealth, electronic signatures, and multimedia elements to optimise participant education.
- Medrio e-consent services provide a secure and user-friendly platform for researchers to obtain informed consent in clinical trials; features include digital signatures, customizable consent templates, and audit trails.
- Medable empowers researchers to streamline the consent process and enhance participant comprehension with e-consent services that include self-service authoring tools for template building, biosample storage consent, and global compliance.
- Clinical Ink offers eSource technology, which helps improve patient comprehension, simplify workloads for sites and study teams, and improve data quality to support decision making and regulatory compliance.
As the clinical research landscape continues to evolve, leveraging technology for e-consent and prescreening is vital to enhance participant experiences and streamline trial processes. The ten companies above offer innovative solutions that cater to the diverse needs of clinical trial professionals, enabling them to conduct studies more efficiently and effectively. By embracing these advanced tools, researchers can drive scientific advancements with confidence.
To learn more about how technology is driving the future of clinical trials, download our free trend report:
